Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.

Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.

Item
http://www.wikidata.org/entity/Q50465037
Surveillance of gastric intestinal metaplasia for the prevention of gastric cancerManagement of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade PortuScreening for and surveillance of gastric cancer.Empirical evidence of the continuing improvement in cost efficiency of an endoscopic surveillance programme for gastric cancer in Singapore from 2004 to 2010.A cost-effectiveness analysis evaluating endoscopic surveillance for gastric cancer for populations with low to intermediate risk.Meta-analysis: The diagnostic efficacy of chromoendoscopy for early gastric cancer and premalignant gastric lesions.Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis.Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies.Cost-utility analysis of endoscopic surveillance of patients with gastric premalignant conditions.Relationship between endoscopic and histologic gastric atrophy and intestinal metaplasia.First degree relatives and familial aggregation of gastric cancer: who to choose for control in case-control studies?Determining the cost-effectiveness of endoscopic surveillance for gastric cancer in patients with precancerous lesions.Endoscopic Submucosal Dissection of Gastric Superficial Lesions: Predictors for Time of Procedure in a Portuguese Center.Evaluation and Management of Gastric Superficial Neoplastic Lesions.Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portug
P2860

Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.

Item
http://www.wikidata.org/entity/Q50465037
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Feasibility and cost-effective ...... tis and intestinal metaplasia.
@en
Feasibility and cost-effective ...... tis and intestinal metaplasia.
@nl
type
label
Feasibility and cost-effective ...... tis and intestinal metaplasia.
@en
Feasibility and cost-effective ...... tis and intestinal metaplasia.
@nl
prefLabel
Feasibility and cost-effective ...... tis and intestinal metaplasia.
@en
Feasibility and cost-effective ...... tis and intestinal metaplasia.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Feasibility and cost-effective ...... tis and intestinal metaplasia.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1440-1746.2007.04863.X
P433
P478
P50
P577
P698